In December of 2014, Forward Science Technologies LLC received another award for its game-changing oral cancer-screening device OralID. The independent Gordon J. Christensen’s Clinicians Report named OralID and CytID among The Best Products of 2014, highlighting OralID and CytID as a complete system for oral mucosal screening. Compared to the classic screening devices, Clinician’s Report evaluators recommend OralID and CytID, stating in the August 2014 report that “OralID is easy to use, least expensive, most simple, and lightest weight.”
President and Chief Technology Officer, Brian Pikkula, Ph.D., recognized the importance of this award. “The Clinicians Report has been an industry standard and go to place for product reviews for decades now. Receiving the award for The Best Product of 2014 […] for OralID and CytID reassures [us] that we are on the right path in providing clinicians with a ‘complete system’ for oral cancer screening.”
Forward Science Technologies was founded on the vision of creating a simpler, more efficient and more affordable oral cancer-screening device to be utilized by more offices, resulting in more lives saved. OralID uses proven fluorescence technology to identify abnormalities in the oral cavity that are often unseen under traditional white light. When coupled with the filtered eyewear, the blue light emitted by OralID allows clinicians to identify cancer, pre-cancer, and other abnormal lesions by their darkness or lack of fluorescence. Being easy-to-use and portable, the award winning OralID device has quickly become a highly regarded device on the market, but it’s the lack of per-patient costs that truly sets OralID apart from previous screening devices.
